Frontispiece: Ruthenium‐Crosslinked Hydrogels with Rapid, Visible‐Light Degradation. Issue 10 (16th February 2018) - Rapp, Teresa L.
Abstract : Light‐responsive hydrogels show promise in targeted drug delivery, as they can load and deliver sensitive cargo when triggered. To make these hydrogels more amenable for use in vivo, I. J. Dmochowski and colleagues have used a nontoxic ruthenium‐based crosslinker to form a hydrogel that degrades upon irradiation with visible light, releasing an active protein cargo. For the full story see the Communication onpage 2328 ff.